
Escolha o seu rótulo
visível diretamente no frascoReta + Cagri Blend
GLP-1
- Enviado da Alemanha
Encomenda
- DHL com seguimento
- Embalagem discreta
Num relance
Reta + Cagri Blend em números
Os valores-chave da nossa enciclopédia.
Entrada completa da enciclopédia- Class
- Triple agonistGLP-1 / GIP / glucagon, + amylin analog
- Half-life
- Retatrutide around 6 dayscagrilintide around 7 to 8 days
- Form
- Lyophilisatepowder, reconstituted with BAC water
- Sizes
- 30 mg1 size in the shop
What studies show
All 5 sources in the lexicon- up to24.2 %Jastreboff et al., NEJM, 2023
- Sanyal et al., Nature Medicine, 2024
- Lau et al., The Lancet, 2021
Avaliações
O que dizem os clientes
Apenas encomendas reais que incluíam Reta + Cagri Blend.
Todas as avaliaçõesAinda não existe análise laboratorial para Reta + Cagri Blend. Vote neleMande testar por conta própria, pagamos metadeTodas as análises laboratoriais
Conhecimento
Tudo sobre Reta + Cagri Blend
Informação detalhada disponível em breve.
Dosagem
A carregar informação de dosagem …
Convém ter
O que precisa para isto
A água bacteriostática é adicionada automaticamente ao carrinho. Seringas e toalhetes com um clique.
Seringas de insulina
10 un. · 5.50 €
Toalhetes com álcool
50 un. · 10 €
Quanta água?
Unidades na seringa para o tamanho do seu frasco.
Abrir calculadora →Is the Reta + Cagri Blend approved or studied?
No. As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Retatrutide and cagrilintide together. Both components are in phase 3 and not approved.
Why Retatrutide and cagrilintide together?
Both act on different satiety pathways: Retatrutide on GLP-1, GIP and glucagon, cagrilintide on amylin receptors. With semaglutide as the partner, weight loss in a phase 1b trial after 20 weeks was 17.1 instead of 9.8 percent. For Retatrutide as the partner there are no data.
What do the studies of the components show?
Retatrutide alone: in TRIUMPH-1 after 80 weeks 25.0 percent less body weight on average at the highest study dose, 3.9 percent on placebo. Cagrilintide alone: up to 10.8 percent after 26 weeks in phase 2, 3.0 percent on placebo. In a substudy liver fat also fell sharply on Retatrutide.
Why is the cagrilintide share so small?
The vial contains five times as much Retatrutide as cagrilintide, because Retatrutide is the stronger and limiting part. Anyone going by the Retatrutide share stays far below the amounts used in the cagrilintide trials. Whether the small share contributes anything has not been studied.
How long do the components stay in the body?
Retatrutide had a half-life of about six days in a phase 1b study, cagrilintide 159 to 195 hours in another study, so about a week. Both fit one dose per week.
Which side effects were seen with the components?
With both, mainly gastrointestinal effects such as nausea and diarrhoea, depending on the dose. On Retatrutide heart rate rose in a dose-dependent way in phase 2. Two satiety signals together may strengthen nausea at the start, this has not been measured for this blend.
Which trials are still running?
Nine phase 3 trials of Retatrutide are running, the largest on heart and kidney events until 2029. The RENEW trials of cagrilintide alone run until 2027. No trial of the blend is listed in the registry.
Relacionados
Produtos relacionados
Tirzepatide
Péptidos · GLP-1 e perda de gordura GLP-1 e perda de gordura
10 tamanhos
Testado em laboratório
= a partir de 10 €/frasco
Retatrutide
Péptidos · GLP-1 e perda de gordura GLP-1 e perda de gordura
11 tamanhos
Testado em laboratório
= a partir de 16 €/frasco
Semaglutide
Péptidos · GLP-1 e perda de gordura GLP-1 e perda de gordura
6 tamanhos
Testado em laboratório
= a partir de 10 €/frasco
Mazdutide
Péptidos · GLP-1 e perda de gordura GLP-1 e perda de gordura
2 tamanhos
= a partir de 32 €/frasco
Reta + Cagri Blend